View Filing Data

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
Document and Entity Information - USD ($) $ in Millions	Jun. 30, 2017	Aug. 21, 2017	Dec. 31, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	SHARPS COMPLIANCE CORP
Entity Central Index Key	0000898770
Current Fiscal Year End Date	--06-30
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Public Float			$ 48.8
Entity Common Stock, Shares Outstanding		16,008,412
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	FY
Document Type	10-K
Amendment Flag	false
Document Period End Date	Jun. 30, 2017

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2017	Jun. 30, 2016
CURRENT ASSETS
Cash and cash equivalents	$ 4,675	$ 12,435
Accounts receivable, net	7,553	5,814
Inventory, net	4,098	3,919
Prepaid and other current assets	694	695
TOTAL CURRENT ASSETS	17,020	22,863
PROPERTY, PLANT AND EQUIPMENT, net	6,543	5,032
OTHER ASSETS	120	84
GOODWILL	6,735	1,039
INTANGIBLE ASSETS, net	4,046	1,129
TOTAL ASSETS	34,464	30,147
CURRENT LIABILITIES
Accounts payable	1,710	1,620
Accrued liabilities	1,800	1,534
Current maturities of long-term debt	601	0
Deferred revenue	2,421	2,477
TOTAL CURRENT LIABILITIES	6,532	5,631
LONG-TERM DEFERRED REVENUE, net of current portion	478	483
OTHER LONG-TERM LIABILITIES	165	190
LONG-TERM DEBT, net of current portion	2,002	0
TOTAL LIABILITIES	9,177	6,304
COMMITMENTS AND CONTINGENCIES (Note 8)
STOCKHOLDERS' EQUITY
Common stock, $0.01 par value per share; 20,000,000 shares authorized; 16,304,027 and 15,740,458 shares issued, respectively and 16,008,412 and 15,444,843 shares outstanding, respectively.	163	158
Treasury stock, at cost, 295,615 shares repurchased	(1,554)	(1,554)
Additional paid-in capital	28,063	25,331
Accumulated deficit	(1,385)	(92)
TOTAL STOCKHOLDERS' EQUITY	25,287	23,843
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 34,464	$ 30,147

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2017	Jun. 30, 2016
STOCKHOLDERS' EQUITY
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	16,304,027	15,740,458
Common stock, shares outstanding (in shares)	16,008,412	15,444,843
Treasury stock, shares repurchased (in shares)	295,615	295,615

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
REVENUES	$ 38,188	$ 33,383	$ 30,902
Cost of revenues	26,351	22,272	19,907
GROSS PROFIT	11,837	11,111	10,995
Selling, general and administrative	12,223	10,812	9,496
Depreciation and amortization	801	294	263
OPERATING INCOME (LOSS)	(1,187)	5	1,236
OTHER INCOME (EXPENSE)
Interest income	13	32	36
Interest expense	(115)	0	0
TOTAL OTHER (EXPENSE) INCOME	(102)	32	36
INCOME (LOSS) BEFORE INCOME TAXES	(1,289)	37	1,272
INCOME TAX EXPENSE - Current	4	24	112
NET INCOME (LOSS)	$ (1,293)	$ 13	$ 1,160
NET INCOME (LOSS) PER COMMON SHARE
Basic (in dollars per share)	$ (0.08)	$ 0	$ 0.08
Diluted (in dollars per share)	$ (0.08)	$ 0	$ 0.07
WEIGHTED AVERAGE SHARES USED IN COMPUTING NET INCOME (LOSS) PER COMMON SHARE:
Basic (in shares)	15,949	15,448	15,327
Diluted (in shares)	15,949	15,838	15,564

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balances at Jun. 30, 2014	$ 155	$ (681)	$ 23,695	$ (1,265)	$ 21,904
Balances (in shares) at Jun. 30, 2014	15,460,940	(161,801)
Exercise of stock options	$ 0	$ 0	139	0	139
Exercise of stock options (in shares)	61,109	0
Stock-based compensation	$ 0	$ 0	511	0	511
Issuance of restricted stock	$ 1	$ 0	(1)	0	0
Issuance of restricted stock (in shares)	52,992	0
Shares repurchased	$ 0	$ (128)	0	0	$ (128)
Shares repurchased (in shares)	0	(29,449)			(29,449)
Net income (loss)	$ 0	$ 0	0	1,160	$ 1,160
Balances at Jun. 30, 2015	$ 156	$ (809)	24,344	(105)	23,586
Balances (in shares) at Jun. 30, 2015	15,575,041	(191,250)
Exercise of stock options	$ 1	$ 0	312	0	313
Exercise of stock options (in shares)	112,425	0
Stock-based compensation	$ 0	$ 0	676	0	676
Issuance of restricted stock	$ 1	$ 0	(1)	0	0
Issuance of restricted stock (in shares)	52,992	0
Shares repurchased	$ 0	$ (745)	0	0	$ (745)
Shares repurchased (in shares)	0	(104,365)			(104,365)
Net income (loss)	$ 0	$ 0	0	13	$ 13
Balances at Jun. 30, 2016	$ 158	$ (1,554)	25,331	(92)	$ 23,843
Balances (in shares) at Jun. 30, 2016	15,740,458	(295,615)			15,444,843
Exercise of stock options	$ 1	$ 0	341	0	$ 342
Exercise of stock options (in shares)	95,050	0
Issuance of common shares for acquisition	$ 4	$ 0	1,895	0	1,899
Issuance of common shares for acquisition (in shares)	415,527	0
Stock-based compensation	$ 0	$ 0	496	0	496
Issuance of restricted stock	$ 0	$ 0	0	0	$ 0
Issuance of restricted stock (in shares)	52,992	0
Shares repurchased (in shares)					0
Net income (loss)	$ 0	$ 0	0	(1,293)	$ (1,293)
Balances at Jun. 30, 2017	$ 163	$ (1,554)	$ 28,063	$ (1,385)	$ 25,287
Balances (in shares) at Jun. 30, 2017	16,304,027	(295,615)			16,008,412

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (1,293)	$ 13	$ 1,160
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	1,485	816	830
Loss on inventory write-down	0	17	0
Loss on disposal of property, plant and equipment	10	0	0
Stock-based compensation expense	496	676	511
Changes in operating assets and liabilities, net of effects of business acquisitions:
Restricted cash	0	0	111
Accounts receivable	(1,244)	926	(1,919)
Legal settlement receivable	0	0	1,538
Inventory	(61)	(1,055)	(1,418)
Prepaid and other assets	(35)	(46)	(259)
Accounts payable and accrued liabilities	125	(759)	1,109
Deferred revenue	(61)	600	499
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	(578)	1,188	2,162
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment	(2,486)	(1,926)	(727)
Cash proceeds from sale of property, plant and equipment	23	0	0
Additions to intangible assets	(163)	0	(6)
Payments for business acquisitions, net of cash acquired	(7,314)	(1,552)	0
NET CASH USED IN INVESTING ACTIVITIES	(9,940)	(3,478)	(733)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	342	313	139
Repayments of long-term debt	(3,184)	0	0
Proceeds from long-term debt	5,600	0	0
Shares repurchased	0	(745)	(128)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	2,758	(432)	11
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(7,760)	(2,722)	1,440
CASH AND CASH EQUIVALENTS, beginning of period	12,435	15,157	13,717
CASH AND CASH EQUIVALENTS, end of period	4,675	12,435	15,157
SUPPLEMENTAL CASH FLOW DISCLOSURES:
Income taxes paid	9	152	58
Interest paid on long-term debt	107	0	0
NON-CASH INVESTING ACTIVITIES:
Issuance of common stock for acquisition	1,899	0	0
Unpaid consideration related to acquisitions	0	181	0
Transfer of equipment to inventory	118	143	0
Property, plant and equipment financed through accounts payable	$ 28	$ 0	$ 0

ORGANIZATION AND BACKGROUND	12 Months Ended
ORGANIZATION AND BACKGROUND	Jun. 30, 2017
ORGANIZATION AND BACKGROUND [Abstract]
ORGANIZATION AND BACKGROUND	NOTE 1 - ORGANIZATION AND BACKGROUND Organization: The accompanying consolidated financial statements include the financial transactions and accounts of Sharps Compliance Corp. and its wholly owned subsidiaries, Sharps Compliance, Inc. of Texas (dba Sharps Compliance, Inc.), Sharps e-Tools.com Inc. (“Sharps e-Tools”), Sharps Manufacturing, Inc., Sharps Environmental Services, Inc. (dba Sharps Environmental Services of Texas, Inc.), Sharps Safety, Inc., Alpha Bio/Med Services LLC, Bio-Team Mobile LLC and Citiwaste, LLC (collectively, “Sharps” or the “Company”). All significant intercompany accounts and transactions have been eliminated upon consolidation. Business: Sharps is a leading full-service national provider of comprehensive waste management services including medial, pharmaceutical and hazardous for small and medium quantity generators. The Company’s solutions include Sharps Recovery System™ (formerly Sharps Disposal by Mail System^®), TakeAway Medication Recovery System™, MedSafe^®, TakeAway Recycle System™,ComplianceTRAC^SM, SharpsTracer^®, Sharps Secure^®Needle Disposal System, Complete Needle™ Collection & Disposal System, TakeAway Environmental Return System™, Pitch-It IV™ Poles, Asset Return System and Spill Kit and Recovery System. The Company also offers route-based pickup services in a twenty-three (23) state region of the South, Southeast and Northeast portions of the United States. Concentration of Customers and Service Providers: There is an inherent concentration of credit risk associated with accounts receivable arising from sales to major customers. For the fiscal year ended June 30, 2017, one customer represented approximately 17% of revenues. This customer also represented approximately 10%, or $0.8 million, of the total accounts receivable balance as of June 30, 2017. For the fiscal year ended June 30, 2016, one customer represented approximately 17% of revenues and 17%, or $1.0 million, of the total accounts receivable balance as of June 30, 2016. For the fiscal year ended June 30, 2015, one customer represented approximately 17% of revenues. The Company may be adversely affected by its dependence on a limited number of high volume customers. Currently, the majority of Sharps transportation is sourced with the United States Postal Service (“USPS”), which consists of delivering the Sharps Recovery System from the end user to the Company’s facilities. The Company also has an arrangement with United Parcel Service Inc. (“UPS”) whereby UPS transports certain of the Company’s products from the end user to the Company’s facilities. Sharps maintains relationships with multiple raw materials suppliers and vendors in order to meet customer demands and assure availability of our products and solutions. With respect to the Sharps Recovery System solutions, the Company owns proprietary molds and dies and utilizes several contract manufacturers for the production of the primary raw materials. Sharps believes that alternative suitable contract manufacturers are readily available to meet the production specifications of our products and solutions. The Company utilizes national suppliers for the majority of the raw materials used in our other products and solutions and international suppliers for Pitch-It IV Poles.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Jun. 30, 2017

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition: The Company recognizes revenue when services are provided and from product sales when (i) goods are shipped or delivered, and title and risk of loss pass to the customer, (ii) the price is substantially fixed or determinable and (iii) collectability is reasonably assured except for those sales via multiple-deliverable revenue arrangements. Provisions for certain rebates, product returns and discounts to customers are accounted for as reductions in sales in the same period the related sales are recorded. Product discounts granted are based on the terms of arrangements with direct, indirect and other market participants, as well as market conditions, including prices charged by competitors. Rebates are estimated based on contractual terms, historical experience, trend analysis and projected market conditions in the various markets served. Service agreements which include a vendor managed inventory program include terms that meet the “bill and hold” criteria and as such are recognized when the order is completed, at which point title has transferred, there are no acceptance provisions and amounts are segregated in the Company’s warehouse. During the fiscal years ended June 30, 2017, 2016 and 2015, the Company recorded revenue from inventory builds that are held in vendor managed inventory under these service agreements of $3.4 million, $3.2 million and $2.6 million, respectively. As of June 30, 2017 and 2016, $2.7 million and $2.1 million, respectively, of solutions sold through that date were held in vendor managed inventory pending fulfillment or shipment to patients of pharmaceutical manufacturers who offer these solutions to patients in an ongoing patient support program.

Certain products offered by the Company have revenue producing components that are recognized over multiple delivery points (Sharps Recovery System and various other solutions like the TakeAway Medication Recovery Systems referred to as “Mailbacks” and Sharps Pump and Asset Return Systems, referred to as “Pump Returns”) and can consist of up to three separate elements, or units of measure, as follows: (1) the sale of the compliance and container system, (2) return transportation and (3) treatment service.

In accordance with the relative selling price methodology, an estimated selling price is determined for all deliverables that qualify for separate units of accounting. The actual consideration received in a multiple-deliverable arrangement is then allocated to the units based on their relative sales price. The selling price for the transportation revenue and the treatment revenue utilizes third party evidence. The Company estimates the selling price of the compliance and container system based on the product and services provided, including compliance with local, state and federal laws, adherence to stringent manufacturing and testing requirements, safety to the patient and the community as well as storage and containment capabilities.

Revenue for the sale of the compliance and container is recognized upon delivery to the customer, at which time the customer takes title and assumes risk of ownership. Transportation revenue is recognized when the customer returns the compliance and container system and the container has been received at the Company’s owned or contracted facilities. The compliance and container system is mailed or delivered by an alternative logistics provider to the Company’s owned or contracted facilities. Treatment revenue is recognized upon the destruction or conversion and proof of receipt and treatment having been performed on the container. Since the transportation element and the treatment elements are undelivered services at the point of initial sale of the compliance and container, transportation and treatment revenue is deferred until the services are performed. The current and long-term portions of deferred revenues are determined through regression analysis and historical trends. Furthermore, through regression analysis of historical data, the Company has determined that a certain percentage of all compliance and container systems sold may not be returned. Accordingly, a portion of the transportation and treatment elements are recognized at the point of sale.

Business Combinations: The Company includes the results of operations of the businesses that are acquired as of the respective dates of acquisition. The Company allocates the fair value of the purchase price of acquisitions to the assets acquired and liabilities assumed based on their estimated fair values. The Company estimates and records the fair value of purchased intangible assets, which primarily consists of customer relationships, trade-names, and non-competes. The excess of the fair value of the purchase price over the fair values of these identifiable assets, both tangible and intangible, and liabilities is recorded as goodwill.

Income Taxes: Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The establishment of a valuation allowance requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets. Under generally accepted accounting principles, the valuation allowance has been recorded to reduce the Company’s deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes.

The income tax provision reflects the full benefit of all positions that have been taken in the Company’s income tax returns, except to the extent that such positions are uncertain and fall below the recognition requirements. In the event that the Company determines that a tax position meets the uncertainty criteria, an additional liability or benefit will result. The amount of unrecognized tax benefit requires management to make significant assumptions about the expected outcomes of certain tax positions included in filed or yet to be filed tax returns. At June 30, 2017 and 2016, the Company did not have any uncertain tax positions. The Company is subject to income taxes in the United States and in numerous state tax jurisdictions. Tax return filings which are subject to review by federal and state tax authorities by jurisdiction are as follows:

United States – fiscal years ended June 30, 2014 and after

State of Texas – fiscal years ended June 30, 2012 and after

State of Georgia – fiscal years ended June 30, 2014 and after

State of Pennsylvania – fiscal years ended June 30, 2014 and after

Other States – fiscal years ended June 30, 2013 and after

None of the Company’s federal or state tax returns are currently under examination. The Company records income tax related interest and penalties, if applicable, as a component of the provision for income tax expense. However, there were no such amounts recognized in the consolidated statements of operations in 2017, 2016 and 2015.

Accounts Receivable: Accounts receivable consist primarily of amounts due to the Company from normal business activities. Accounts receivable balances are determined to be delinquent when the amount is past due based on the contractual terms with the customer. The Company maintains an allowance for doubtful accounts to reflect the likelihood of not collecting certain accounts receivable based on past collection history and specific risks identified among uncollected accounts. Accounts receivable are charged to the allowance for doubtful accounts when the Company determines that the receivable will not be collected and/or when the account has been referred to a third-party collection agency. The Company has a history of minimal uncollectible accounts. See rollforward of allowance activity below:

Allowance for Doubtful Accounts	Balance Beginning of Year		Charges to Expense		Write-offs /Payments			Balance End of Year

2017	$	63	$	20	$	(5	)	$	78
2016	$	34	$	34	$	(5	)	$	63
2015	$	23	$	22	$	(11	)	$	34

Stock-Based Compensation: Stock-based compensation cost for options and restricted stock awarded to employees and directors is measured at the grant date, based on the calculated fair value of the award and is recognized as an expense over the employee’s requisite service period (generally the vesting period of the equity grant). Total stock-based compensation expense for the fiscal years ended June 30, 2017, 2016 and 2015 are as follows:

	Year Ended June 30,
	2017		2016		2015
Stock-based compensation expense included in:
Cost of revenue	$	41	$	31	$	22
Selling, general and administrative		455		645		489
Total	$	496	$	676	$	511

The Company estimates the fair value of restricted stock awards based on the closing price of the Company’s common stock on the date of the grant. The Company estimates the fair value of stock options using the Black-Scholes valuation model. Key input assumptions used to estimate the fair value of stock options include the exercise price of the award, the expected option term, the expected volatility of the Company’s stock over the option’s expected term, the risk free interest rate over the option’s expected term and the Company’s expected annual dividend yield. The risk free interest rate is derived using the U.S. Treasury yield curve in effect at date of grant. Volatility, expected life and dividend yield are based on historical experience and activity.

The fair value of the Company’s stock options was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:

	Year Ended June 30,
	2017			2016			2015

Weighted average risk-free interest rate		1.1	%		1.0	%		0.4	%
Weighted average expected volatility		47	%		45	%		45	%
Weighted average expected life (in years)		5.15			4.56			3.49
Dividend yield		-			-			-

The Company considers an estimated forfeiture rate for stock options based on historical experience and the anticipated forfeiture rates during the future contract life.

Cash and Cash Equivalents: The Company considers all highly liquid investments with a maturity of three months or less at the time of purchase to be cash equivalents. The Company maintains funds in bank accounts that, at times, may exceed the limit insured by the Federal Deposit Insurance Corporation (“FDIC”). The risk of loss attributable to these uninsured balances is mitigated by depositing funds only in high credit quality financial institutions. The Company has not experienced any losses in such accounts.

Inventory: Inventory consists primarily of raw materials and finished goods held for sale and are stated at the lower of cost or market using the average cost method. The Company periodically reviews the value of items in inventory and provides write-downs or write-offs of inventory based on its assessment of physical deterioration, obsolescence, changes in price levels and other causes. At June 30, 2017, total inventory was $4.1 million of which $2.8 million was finished goods, and $1.3 million was raw materials. At June 30, 2016, total inventory was $3.9 million of which $2.5 million was finished goods, and $1.4 million was raw materials. There were no write-downs of inventory for the fiscal years ended June 30, 2017 and 2015. Total write-downs for the fiscal year ended June 30, 2016 were $17,000 and were included in cost of goods sold.

Property, Plant and Equipment: Property, plant and equipment, including third party software and implementation costs, is stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method based on the estimated useful lives of the assets. Additions, improvements and renewals significantly adding to the asset value or extending the life of the asset are capitalized. Ordinary maintenance and repairs, which do not extend the physical or economic life of the property or equipment, are charged to expense as incurred. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in the results of operations for the period.

Computer and software development costs, which include costs of computer software developed or obtained for internal use, all programming, implementation and costs incurred with developing internal-use software, are capitalized during the development project stage. External direct costs of materials and services consumed in developing or obtaining internal-use computer software are capitalized.

The Company expenses costs associated with developing or obtaining internal-use software during the preliminary project stage. Training and maintenance costs associated with system changes or internal-use software are expensed as incurred. Additionally, the costs of data cleansing, reconciliation, balancing of old data to the new system, creation of new/additional data and data conversion costs are expensed as incurred.

Goodwill and Other Identifiable Intangible Assets: Finite-lived intangible assets are amortized over their respective estimated useful lives and evaluated for impairment periodically whenever events or changes in circumstances indicate that their related carrying values may not be fully recoverable. Goodwill is assessed for impairment at least annually. The Company generally performs its annual goodwill impairment analysis using a quantitative approach. The quantitative goodwill impairment test identifies the existence of potential impairment by comparing the fair value of our single reporting unit with its carrying value, including goodwill. If the fair value of a reporting unit exceeds its carrying value, the reporting unit’s goodwill is considered not to be impaired. If the carrying value of a reporting unit exceeds its fair value, an impairment charge is recognized in an amount equal to that excess. The impairment charge recognized is limited to the amount of goodwill present in our single reporting unit. These estimates and assumptions could have a significant impact on whether or not an impairment charge is recognized and the amount of any such charge.

The Company performs its annual impairment assessment of goodwill during the fourth quarter of each fiscal year. The Company determined that there was no impairment during the years ended June 30, 2017, 2016 and 2015.

Intangible Assets: Intangible assets consist of (i) acquired customer relationships, (ii) permit costs related to the Company’s treatment facilities and transfer stations, and (iii) eleven patents (two acquired in June 1998, one in November 2003, one in January 2012, two in April 2012, one in August 2012, one in September 2012, one in December 2012, one in November 2013 and one in January 2014), and (iv) defense costs related to certain existing patents.

Shipping and Handling Fees and Costs: The Company records amounts billed to customers for shipping and handling as revenue. Costs incurred by the Company for shipping and handling have been classified as cost of revenues.

Additional Product Related Costs: The Company records inbound shipping, purchasing and receiving costs, inspection costs, warehousing costs and other product related costs as cost of revenues.

Advertising Costs: Advertising costs are charged to expenses when incurred and totaled $0.8 million, $0.6 million and $0.6 million for the fiscal years ended June 30, 2017, 2016 and 2015, respectively.

Research and Development Costs: Research and development costs are charged to expense when incurred. Research activities represent an important part of the Company’s business and include both internal labor costs and payments to third parties related to the processes of discovering, testing and developing new products, improving existing products, as well as demonstrating product efficacy and regulatory compliance prior to launch of new products and services. Research and development expenses paid to third parties totaled less than $0.1 million for each of the fiscal years ended June 30, 2017, 2016 and 2015.

Realization of Long-lived Assets: The Company evaluates the recoverability of property, plant and equipment and intangible or other assets if facts and circumstances indicate that any of those assets might be impaired. If an evaluation is required, the estimated future undiscounted cash flows associated with the asset are compared to the asset’s carrying amount to determine if a write-down to fair value is necessary. No impairment loss was recognized during the years ended June 30, 2017, 2016 and 2015.

Employee Benefit Plans: In addition to group health-related benefits, the Company maintains a 401(k) employee savings plan available to all full-time employees. The Company matches a portion of employee contributions with cash (25% of employee contribution up to 6%). Company contributions to the 401(k) plan were less than $0.1 million in each of the fiscal years ended June 30, 2017, 2016 and 2015, respectively and are included in selling, general and administrative expenses. For purposes of the group health benefit plan and beginning February 1, 2016, the Company self-insures an amount equal to the excess of the employees’ deductible (range from $2,500 for each individual and family member covered) up to the amount by which the third-party insurance coverage begins (ranges from $2,500 for individual up to $10,000 for family coverage). The amount of liability at June 30, 2017 and 2016 was less than $0.1 million and is included in accrued liabilities. The Company has an incentive plan for executives of the Company, which provides for cash and stock-based compensation awards. The aggregate expense recognized during the year ended June 30, 2017, 2016 and 2015 for the cash awards pursuant to the plan was $0, $0 and $0.3 million, respectively.

Net Income (Loss) Per Share: Basic earnings per share excludes dilution and is determined by dividing income available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS reflects the potential dilution that could occur if securities and other contracts to issue common stock were exercised or converted into common stock.

Fair Value of Financial Instruments: The Company considers the fair value of all financial instruments, including cash and cash equivalents, accounts receivable and accounts payable to approximate their carrying values at year-end due to their short-term nature. The carrying value of the Company’s debt approximates fair value due to the market rates of interest.

Fair Value Measurements: The Company employs a hierarchy which prioritizes the inputs used to measure recurring fair value into three distinct categories based on the lowest level of input that is significant to the fair value measurement. Our methodology for categorizing assets and liabilities that are measured at fair value pursuant to this hierarchy gives the highest priority to unadjusted quoted prices in active markets and the lowest levels to unobservable inputs, summarized as follows:

Level 1 – Quoted prices in active markets for identical assets or liabilities.

Level 2 – Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities).

Level 3 – Significant unobservable inputs (including our own assumptions in determining fair value).

We use the cost, income or market valuation approaches to estimate the fair value of our assets and liabilities when insufficient market-observable data is available to support our valuation assumptions. The purchase price allocations relating to the acquisitions completed during the years ended June 30, 2017 and 2016 utilized level 3 inputs.

Segment Reporting: The Company operates in a single segment, focusing on developing cost-effective management solutions for medical waste and unused dispensed medications generated by small and medium quantity generators.

Use of Estimates: The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expense during the reporting period. The Company uses estimates to determine many reported amounts, including but not limited to allowance for doubtful accounts, recoverability of long-lived assets and intangibles, useful lives used in depreciation and amortization, income taxes and valuation allowances, stock-based compensation, fair values of assets and liabilities acquired in business combinations, selling price used in multiple-deliverable arrangements and return rates used to estimate the percentage of container systems sold that will not be returned. Actual results could differ from these estimates.

Recently Issued Accounting Standards: In May 2014, guidance for revenue recognition was issued which supersedes the revenue recognition requirements currently followed by the Company. The new guidance provides for a single five-step model to be applied in determining the amount and timing of the recognition of revenue related to contracts with customers. The new standard also requires additional financial statement disclosures that will enable users to understand the nature, amount, timing and uncertainty of revenue and cash flows relating to customer contracts. In March 2016, guidance for revenue from contracts with customers regarding principal versus agent considerations was issued which modified examples to assist in the application of the guidance. Companies have an option to use either a retrospective approach or cumulative effect adjustment approach to implement the standard. The guidance is effective for annual reporting periods beginning after December 15, 2017 (effective July 1, 2018 for the Company). The Company is in the initial stages of evaluating the impact that the new accounting guidance will have on its consolidated financial statements and related disclosures as well as evaluating the available transition methods. The Company will continue to evaluate the standard as well as additional changes, modifications or interpretations which may impact the Company.

In July 2015, guidance for inventory measurement was issued, which supersedes the policy currently followed by the Company. The new guidance requires the Company to measure inventory at the lower of cost and net realizable value. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within that reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures.

In February 2016, guidance for leases was issued, which requires balance sheet recognition for rights and obligations of all leases with terms in excess of twelve months. The new guidance also requires additional disclosures about the amount, timing and uncertainty of cash flows arising from leases. The provisions of the new guidance are effective for annual periods beginning after December 15, 2018 (effective July 1, 2019 for the Company), including interim periods within the reporting period, and early application is permitted. The Company is in the initial stages of evaluating the impact of the new guidance on its consolidated financial statements and related disclosures.

In March 2016, new guidance for stock-based compensation was issued, which simplifies the accounting for stock-based compensation related to income taxes and balance sheet and cash flow classifications. In addition, an entity can make an entity-wide accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures when they occur. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2016 (effective July 1, 2017 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures.

In January 2017, guidance for goodwill was issued which simplifies the test for goodwill impairment. The new guidance eliminates Step 2 of the goodwill impairment test and requires a goodwill impairment to be measured as the amount by which the Company’s carrying amount exceeds its fair value, not to exceed the carrying amount of its goodwill. The provisions of the new guidance are effective for annual reporting periods beginning after December 15, 2019 (effective July 1, 2020 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2017 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures; however, it may impact the impairment recognized in future periods.

In September 2015, guidance for business combinations was issued, which simplifies the accounting for measurement-period adjustments. The new guidance eliminates the requirement to restate prior period financial statements for measurement period adjustments following a business combination and requires that the cumulative impact of a measurement period adjustment (including the impact on prior periods) be recognized in the reporting period in which the adjustment is identified. The provisions of the new guidance were effective for annual reporting periods beginning after December 15, 2015 (effective July 1, 2016 for the Company) including interim periods within the reporting period. The Company adopted this guidance on July 1, 2016 and it did not have a material effect on the Company’s consolidated financial statements and related disclosures; however, it may impact the reporting of future acquisitions if and when they occur.

PROPERTY, PLANT AND EQUIPMENT

12 Months Ended

Jun. 30, 2017

PROPERTY, PLANT AND EQUIPMENT [Abstract]

PROPERTY, PLANT AND EQUIPMENT

NOTE 3 – PROPERTY, PLANT AND EQUIPMENT

At June 30, 2017 and 2016, property, plant and equipment consisted of the following (in thousands):

		June 30,
	Useful Life	2017		2016
Furniture and fixtures	3 to 5 years	$	260	$	247
Plant and equipment	3 to 17 years		7,975		6,524
Manufacturing	15 years		220		220
Computers and software	3 to 5 years		2,246		2,009
Leasehold improvements	Life of Lease		2,681		964
Land			19		19
Construction-in-progress			347		1,372
			13,748		11,355
Less: accumulated depreciation			7,205		6,323

Net property, plant and equipment		$	6,543	$	5,032

Total depreciation and amortization expense in the fiscal years ended June 30, 2017, 2016 and 2015 was $0.9 million, $0.7 million and $0.8 million, respectively. Depreciation expense included in cost of revenues in the fiscal years ended 2017, 2016 and 2015 was $0.7 million, $0.5 million and $0.6 million, respectively.

INCOME TAXES

12 Months Ended

Jun. 30, 2017

INCOME TAXES [Abstract]

INCOME TAXES

NOTE 4 – INCOME TAXES

The components of income tax expense are as follows (in thousands):

	Year ended June 30,
	2017		2016		2015

Current
Federal	$	-	$	-	$	29
State		4		24		83
	$	4	$	24	$	112

The reconciliation of the statutory income tax rate to the Company’s effective income tax rate for the fiscal years ended June 30, 2017, 2016 and 2015 is as follows:

	Year Ended June 30,
	2017			2016			2015

Statutory rate		34.0	%		34.0	%		34.0	%
State income taxes, net		(4.5	%)		(18.6	%)		5.3	%
Meals and entertainment		(1.5	%)		38.7	%		1.2	%
AMT and research and development credits		0.0	%		(218.9	%)		0.0	%
Other		0.2	%		1.5	%		0.0	%
Effective rate before valuation allowance		28.2	%		(163.3	%)		40.5	%

Change in valuation allowance		(28.5	%)		228.2	%		(31.7	%)
Effective tax rate		(0.3	%)		64.9	%		8.8	%

A valuation allowance has been recorded to reduce the Company’s net deferred tax assets to an amount that is more likely than not to be realized and is based upon the uncertainty of the realization of certain federal and state deferred tax assets related to net operating loss carryforwards and other tax attributes. The establishment of valuation allowances and development of projected annual effective tax rates requires significant judgment and is impacted by various estimates. Both positive and negative evidence, as well as the objectivity and verifiability of that evidence, is considered in determining the appropriateness of recording a valuation allowance on deferred tax assets.

At June 30, 2017 and 2016, the significant components of deferred tax assets and liabilities are approximated as follows (in thousands):

	June 30,
	2017			2016
Deferred tax assets relating to:
Stock compensation	$	398		$	627
AMT and research and development credits		523			523
Deferred rent		77			82
Inventory		211			169
Professional fees		155			140
Accrued vacation		43			33
Accounts receivable allowance		49			24
Contribution carryovers		12			8
Net operating loss carryforwards		1,443			1,044
Total deferred tax assets		2,911			2,650
Deferred tax liablities related to depreciation differences		(783	)		(621	)
Net deferred tax assets before valuation allowance		2,128			2,029
Valuation allowance		(2,128	)		(2,029	)
Net deferred tax assets	$	-		$	-

At June 30, 2017, the Company had net operating loss carryforwards of $4.8 million which will expire, if unused, between June 30, 2032 and June 30, 2037. At June 30, 2017, the Company had various tax credit carryforwards of $0.5 million, of which $0.3 million will expire beginning on June 30, 2030 and $0.2 million which may be carried forward indefinitely.

As of June 30, 2017, the Company’s estimated net operating losses for tax return filing purposes exceeds the gross amount for financial reporting purposes by $0.6 million related to excess income tax benefits on stock-based compensation. The tax effect of this excess tax expense will be offset by the valuation allowance and have no net effect.

NOTES PAYABLE AND LONG-TERM DEBT

12 Months Ended

Jun. 30, 2017

NOTES PAYABLE AND LONG-TERM DEBT [Abstract]

NOTES PAYABLE AND LONG-TERM DEBT

NOTE 5 - NOTES PAYABLE AND LONG-TERM DEBT

On March 29, 2017, the Company entered into to a credit agreement with a commercial bank (the “Credit Agreement”). The Credit Agreement, which replaced the Company’s prior credit agreement, provides for a $14.0 million credit facility, the proceeds of which may be utilized as follows: (i) $6.0 million for working capital, letters of credit (up to $2.0 million) and general corporate purposes and (ii) $8.0 million for acquisitions. Indebtedness under the Credit Agreement is secured by substantially all of the borrower’s assets with advances outstanding under the working capital portion of the credit facility at any time limited to a Borrowing Base (as defined in the Credit Agreement) equal to 80% of eligible accounts receivable plus the lessor of 50% of eligible inventory and $3 million. Advances under the acquisition portion of the credit facility are limited to 75% of the purchase price of an acquired company and convert to a five-year term note at the time of the borrowing. Borrowings bear interest at the greater of (a) zero percent or (b) the One Month ICE LIBOR plus a LIBOR Margin of 2.5%. The LIBOR Margin may increase to as high as 3.0% after September 30, 2017 depending on the Company’s cash flow leverage ratio. The interest rate as of June 30, 2017 was approximately 3.63%. The Company pays a fee of 0.25% per annum on the unused amount of the credit facility.

At June 30, 2017, long-term debt consisted of the following (in thousands):

Non-interest bearing, unsecured note payable assumed in acquisition (See Note 12), monthly payments of $7; maturing September 2018.	$	104

Term loan, bearing interest at 3.63%, monthly payments of $43; maturing March 2022.		2,499

Total long-term debt		2,603
Less: current portion		601
Long-term debt, net of current portion	$	2,002

The Company has availability under the Credit Agreement of $11.5 million ($6.0 million for the working capital and $5.5 million for the acquisitions) as of June 30, 2017 which may be limited by its leverage covenant. The Company also has $10,000 in letters of credit outstanding as of June 30, 2017.

The Credit Agreement contains affirmative and negative covenants that, among other things, require the Company to maintain, beginning with the twelve-month period ending September 30, 2017, a maximum cash flow leverage ratio of no more than 3.5 to 1.0 and a minimum debt service coverage ratio of not less than 1.15 to 1.00. The maximum cash flow leverage ratio decreases to 3.25 to 1.0 on December 31, 2017 and to 3.0 to 1.0 on March 31, 2018. The Credit Agreement, which expires on March 29, 2019, also contains customary events of default which, if uncured, may terminate the Credit Agreement and require immediate repayment of all indebtedness to the lenders.

Payments due on long-term debt during each of the five years subsequent to June 30, 2017 are as follows (in thousands):

Twelve Months Ending June 30,
2018	$	601
2019		537
2020		517
2021		517
2022		431
	$	2,603

The prior credit agreement, which was effective through March 29, 2017, provided for a $9.0 million line of credit facility with a maturity date of April 9, 2018. No amounts related to the prior credit agreement were outstanding as of June 30, 2017.

EQUITY TRANSACTIONS

12 Months Ended

Jun. 30, 2017

EQUITY TRANSACTIONS [Abstract]

EQUITY TRANSACTIONS

NOTE 6 - EQUITY TRANSACTIONS

On January 7, 2013, the Company announced that its Board of Directors approved a stock repurchase program effective January 3, 2013, authorizing the Company to repurchase in the aggregate up to $3 million of its outstanding common stock over a two-year period. On March 5, 2015, the Board approved a two-year extension of the stock repurchase program through January 1, 2017. The program has not been extended.During the years ended June 30, 2017, 2016 and 2015, shares were repurchased as follows:

	Year Ended June 30,
	2017		2016		2015

Shares repurchased		-		104,365		29,449
Cash paid for shares repurchased (in thousands)	$	-	$	745	$	128
Average price paid per share	$	-	$	7.14	$	4.35

Total shares repurchased under the program are 295,615 shares at a cost of $1.6 million.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

STOCK BASED COMPENSATION

12 Months Ended

Jun. 30, 2017

STOCK BASED COMPENSATION [Abstract]

STOCK BASED COMPENSATION

NOTE 7 - STOCK BASED COMPENSATION

The Company sponsors the Sharps Compliance Corp. 2010 Stock Plan (the “2010 Plan”) covering employees, consultants and non-employee directors. The 2010 Stock Plan replaced the Sharps Compliance Corp. 1993 Stock Plan (the “1993 Plan”). The 2010 Plan provides for the granting of stock-based compensation (stock options or restricted stock) of up to 3,000,000 shares of the Company’s common stock of which 877,904 options and restricted shares are outstanding as of June 30, 2017. Options granted generally vest over a period of three to four years and expire seven years after the date of grant. Restricted stock generally vests over one year. There are no remaining options outstanding under the 1993 Plan. As of June 30, 2017, there were 1,561,891 options available for grant under the 2010 Plan.

The summary of activity for all restricted stock during the fiscal years ended June 30, 2017, 2016 and 2015 is presented in the table below (in thousands):

	Year Ended June 30,
	2017			2016			2015

Unvested at beginning of the year		13			13			15
Granted		53			53			53
Vested		(53	)		(53	)		(55	)
Unvested at end of the year		13			13			13

The weighted average fair value per share of restricted stock granted during the fiscal years ended June 30, 2017, 2016 and 2015 was $4.38, $8.00 and $4.28, respectively. The weighted average fair value per share of restricted stock which vested during the fiscal years ended June 30, 2017, 2016 and 2015 was $5.29, $7.07 and $4.44, respectively.

The summary of activity for all stock options during the fiscal years ended June 30, 2017, 2016 and 2015 is presented in the table below (in thousands except per share amounts):

	Options Outstanding			Weighted Average Exercise Price
Options Outstanding at June 30, 2014		950		$	4.27
Granted		516		$	4.63
Exercised		(61	)	$	2.30
Forfeited or canceled		(30	)	$	4.68

Options Outstanding at June 30, 2015		1,375		$	4.49
Granted		45		$	6.62
Exercised		(112	)	$	2.77
Forfeited or canceled		(18	)	$	5.99

Options Outstanding at June 30, 2016		1,290		$	4.69
Granted		38		$	4.55
Exercised		(95	)	$	3.60
Forfeited or canceled		(368	)	$	5.32

Options Outstanding at June 30, 2017		865		$	4.53

Options Exercisable at June 30, 2017		561		$	4.39

The following table summarizes information about stock options outstanding as of June 30, 2017 (in thousands except per share amounts):

			Options Outstanding
Range of Exercise Price			Outstanding as of June 30, 2017		Weighted Average Remaining Life (in Years)		Weighted Average Exercise Price

	$	2.51 - $3.50		41		2.49		$	2.95
	$	3.51 - $5.50		692		3.27		$	4.35
	$	5.51 - $7.50		132		4.82		$	5.97
				865				$	4.53

The following table summarizes information about stock options exercisable as of June 30, 2017 (in thousands except per share amounts):

		Options Exercisable
Range of Exercise Price		Exercisable as of June 30, 2017		Weighted Average Remaining Life (in Years)		Weighted Average Exercise Price

$	2.51 - $3.50		39		2.46	$	2.96
$	3.51 - $5.50		464		2.66	$	4.32
$	5.51 - $7.50		58		4.78	$	5.87
			561			$	4.39

As of June 30, 2017, there was $0.2 million of stock option and restricted stock compensation expense related to non-vested awards. This expense is expected to be recognized over a weighted average period of 1.6 years.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

COMMITMENTS AND CONTINGENCIES

12 Months Ended

Jun. 30, 2017

COMMITMENTS AND CONTINGENCIES [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 8 - COMMITMENTS AND CONTINGENCIES

Operating Leases: The Company operates in a number of locations across the U.S. including space for corporate offices in Houston, Texas. Sharps has manufacturing, assembly, storage, distribution and warehousing operations as well as two (2) fully-permitted facilities that house our processing and treatment operations. The Company owns one processing and treatment facility and leases all other spaces. The leases expire between 2020 to 2023 with options to renew ranging from 3 years to 10 years.

Rent expense for the fiscal years ended June 30, 2017, 2016 and 2015 was $2.3 million, $1.5 million and $1.3 million, respectively. Future minimum lease payments under non-cancelable operating leases as of June 30, 2017 are as follows (in thousands):

	Year Ended June 30,
	2018		2019		2020		2021		2022		Thereafter
Operating lease obligations	$	1,812	$	1,827	$	1,725	$	943	$	274	$	5

Performance Bonds: The Company also utilizes performance bonds to support operations based on certain state requirements. At June 30, 2017, the Company had performance bonds outstanding covering financial assurance up to $0.6 million.

Other: From time to time, the Company is involved in legal proceedings and litigation in the ordinary course of business. In the opinion of management, the outcome of such matters will not have a material adverse effect on the Company’s consolidated financial position or consolidated results of operations.

EARNINGS PER SHARE

12 Months Ended

Jun. 30, 2017

EARNINGS PER SHARE [Abstract]

EARNINGS PER SHARE

NOTE 9 - EARNINGS PER SHARE

Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) by the weighted average number of common shares after considering the additional dilution related to common stock options and restricted stock. In computing diluted earnings per share, the outstanding common stock options are considered dilutive using the treasury stock method.

The Company’s restricted stock awards are treated as outstanding for earnings per share calculations since these shares have full voting rights and are entitled to participate in dividends declared on common shares, if any, and undistributed earnings. As participating securities, the shares of restricted stock are included in the calculation of basic EPS using the two-class method. For the periods presented, the amount of earnings allocated to the participating securities was not material.

The following information is necessary to calculate earnings per share for the periods presented (in thousands, except per share amounts):

	Year Ended June 30,
	2017			2016		2015

Net income (loss), as reported	$	(1,293	)	$	13	$	1,160

Weighted average common shares outstanding		15,949			15,448		15,327
Effect of dilutive stock options		-			390		237
Weighted average diluted common shares outstanding		15,949			15,838		15,564

Net income (loss) per common share
Basic	$	(0.08	)	$	0.00	$	0.08
Diluted	$	(0.08	)	$	0.00	$	0.07

Employee stock options excluded from computation of diluted income per share amounts because their effect would be anti-dilutive		304			137		210

GOODWILL AND INTANGIBLE ASSETS

12 Months Ended

Jun. 30, 2017

GOODWILL AND INTANGIBLE ASSETS [Abstract]

GOODWILL AND INTANGIBLE ASSETS

NOTE 10 – GOODWILL AND INTANGIBLE ASSETS

At June 30, 2017 and June 30, 2016, intangible assets consisted of the following (in thousands):

		June 30,
		2017							2016
	Estimated Useful Lives	Original Amount		Accumulated Amortization			Net Amount		Original Amount		Accumulated Amortization			Net Amount

Customer relationships	7 years	$	3,007	$	(490	)	$	2,517	$	580	$	(60	)	$	520
Permits	6 - 15 years		1,373		(288	)		1,085		668		(191	)		477
Patents	5 - 17 years		383		(264	)		119		383		(251	)		132
Tradename	7 years		270		(39	)		231		-		-			-
Non-compete	5 years		117		(23	)		94		-		-			-
Total intangible assets, net		$	5,150	$	(1,104	)	$	4,046	$	1,631	$	(502	)	$	1,129

During the years ended June 30, 2017, 2016 and 2015 amortization expense was $0.6 million, $0.1 million and $0.1 million, respectively.

The changes in the carrying amount of goodwill since June 30, 2015 was as follows (in thousands):

	Year Ended June 30,
	2017		2016
Beginning Balance	$	1,039	$	-
Goodwill Acquired		5,696		1,039
Ending Balance	$	6,735	$	1,039

As of June 30, 2017, future amortization of intangible assets is as follows (in thousands):

Year Ending June 30,
2018	$	616
2019		616
2020		616
2021		615
2022		590
Thereafter		993
	$	4,046

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

REVENUES BY SOLUTION

12 Months Ended

Jun. 30, 2017

REVENUES BY SOLUTION [Abstract]

REVENUES BY SOLUTION

NOTE 11 – REVENUES BY SOLUTION

The components of revenues by solution are as follows (dollars in thousands):

	Year Ended June 30,
	2017		% Total			2016		% Total			2015		% Total
REVENUES BY SOLUTION:
Mailbacks	$	24,135		63.2	%	$	23,743		71.1	%	$	23,043		74.6	%
Route-based pickup services		6,348		16.6	%		2,061		6.2	%		862		2.8	%
Unused medications		3,377		8.8	%		3,531		10.6	%		2,667		8.6	%
Third party treatment services		413		1.1	%		258		0.8	%		367		1.2	%
Other⁽¹⁾		3,915		10.3	%		3,790		11.3	%		3,963		12.8	%
Total revenues	$	38,188		100.0	%	$	33,383		100.0	%	$	30,902		100.0	%

(1)

The Company’s other products include non-mailback products such as IV poles, accessories, containers, asset return boxes and other miscellaneous items.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

+ Details

ACQUISITIONS

12 Months Ended

Jun. 30, 2017

ACQUISITIONS [Abstract]

ACQUISITIONS

NOTE 12 – ACQUISITIONS

Effective on July 17, 2015, the Company acquired Alpha Bio/Med Services LLC, a route-based pickup service located in Pennsylvania for total cash consideration of $0.7 million of which $0.1 million was withheld for payment of adjusted escrow amounts which settled in July 2016.

The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands):

Accounts receivable	$	51
Fixed assets		70
Intangibles		267
Goodwill		413
Accounts payable and accrued liabilities		(101	)
Total purchase price	$	700

Effective on December 14, 2015, the Company acquired Bio-Team Mobile LLC, a route-based pickup service located in Pennsylvania for total cash consideration of $1.0 million of which $0.1 million was withheld for payment of adjusted escrow amounts which settled in January 2017.

The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands):

Accounts receivable	$	42
Fixed assets		68
Intangibles		313
Goodwill		626
Accounts payable and accrued liabilities		(16	)
Total purchase price	$	1,033

Effective July 1, 2016, the Company acquired Citiwaste, LLC (“Citiwaste”), a route-based pickup service located in New York, which is in the business of medical, pharmaceutical and hazardous waste management primarily in the healthcare industry. The purchase price consisted of $7.0 million in cash ($3.0 million of which was borrowed under the acquisition portion of its Credit Agreement), 415,527 shares of common stock of the Company (the “Common Stock Consideration”) valued at $1.9 million, and a lease obligation paid to the seller for $0.1 million for a total consideration of $9.0 million. The issuance of the Common Stock Consideration was not registered under the Securities Act of 1933, as amended, and was issued pursuant to an exemption from the registration requirements thereunder. The Company held shares of the Common Stock Consideration in escrow for the one-year period to cover indemnification obligations of the sellers under the purchase agreement which were released on June 30, 2017.

For the year ended June 30, 2017, the Company recognized approximately $3.6 million in revenues related to the operations of Citiwaste.

The following amounts represent the fair value of the assets acquired and liabilities assumed (in thousands):

Cash	$	5
Accounts receivable		495
Fixed assets		30
Intangibles		3,357
Goodwill		5,696
Accounts payable and accrued liabilities		(356	)
Debt assumed		(187	)
Total purchase price	$	9,040

The Company incurred acquisition related expenses for investment banking, legal and accounting fees which are included within selling, general and administrative expenses in the consolidated statements of operations as follows (in thousands):

	Twelve-Months Ended June 30,
	2017		2016		2015

Acquisition-related expenses	$	702	$	190	$	-

The results of operations of the acquired business have been included in the consolidated statements of operations from the date of acquisition. Pro forma results of operations for Alpha Bio/Med Services and Bio-Team Mobile are not presented because the pro forma effects, individually or in the aggregate, were not material to the Company’s consolidated results of operations. The goodwill recorded for the Alpha Bio/Med Services, Bio-Team Mobile, and Citiwaste acquisitions will be deductible for income taxes.

The goodwill recognized for the acquisitions since July 1, 2015 is attributable to expected revenue synergies generated by the integration of our products and services with those acquisitions, cost synergies resulting from the consolidation or elimination of certain functions, and intangible assets that do not qualify for separate recognition such as the assembled workforce of each acquisition.

Supplemental Pro Forma Data (Unaudited)

Citiwaste’s financial results since the date of the acquisition have been included in our consolidated financial results for the year ended June 30, 2017. The following table presents summarized unaudited pro forma financial information as if the Citiwaste acquisition occurred on July 1, 2015 (in thousands, except per-share data):

	Twelve-Months Ended June 30,
	2016

Revenues	$	36,306
Net income (loss)	$	(159	)
Weighted average common shares outstanding		15,861
Net loss per common share basic and diluted	$	(0.01	)

The pro forma financial information for the period presented includes the estimated business combination accounting effects resulting from the acquisition, including primarily amortization expense of $0.5 million from the acquired intangible assets as well as interest expense as a result of debt financing used to fund the acquisition and tax effects from the pro forma adjustments.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1524-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4922-128472

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4934-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=73530397&loc=d3e4926-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=73530397&loc=SL65897772-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65885119&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

SELECTED QUARTERLY FINANCIAL DATA

12 Months Ended

Jun. 30, 2017

SELECTED QUARTERLY FINANCIAL DATA [Abstract]

SELECTED QUARTERLY FINANCIAL DATA

NOTE 13 – SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)

The following tables show quarterly financial information for the years ended June 30, 2017 and 2016. The Company believes that all necessary adjustments have been included in the amounts below to present fairly the results of such periods (in thousands expect per share amounts).

	Quarter Ended
	September 30, 2016			December 31, 2016			March 31, 2017			June 30, 2017
Total revenues	$	9,531		$	9,707		$	8,588		$	10,362
Gross profit	$	2,959		$	2,895		$	2,352		$	3,631
Operating income (loss)	$	(940	)	$	(204	)	$	(638	)	$	595
Net income (loss)	$	(967	)	$	(227	)	$	(668	)	$	569
Net income (loss) per share - basic and diluted	$	(0.06	)	$	(0.01	)	$	(0.04	)	$	0.04
Weighted average shares-diluted		15,868			15,929			15,994			16,029

	Quarter Ended
	September 30, 2015		December 31, 2015		March 31, 2016			June 30, 2016
Total revenues	$	7,869	$	9,992	$	6,652		$	8,870
Gross profit	$	2,879	$	3,319	$	1,693		$	3,220
Operating income (loss)	$	231	$	664	$	(1,104	)	$	214
Net income (loss)	$	220	$	615	$	(1,042	)	$	220
Net income (loss) per share - basic and diluted	$	0.01	$	0.04	$	(0.07	)	$	0.01
Weighted average shares-diluted		15,926		16,062		15,462			15,575

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Jun. 30, 2017

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]

Revenue Recognition

Business Combinations

Income Taxes

United States – fiscal years ended June 30, 2014 and after

State of Texas – fiscal years ended June 30, 2012 and after

State of Georgia – fiscal years ended June 30, 2014 and after

State of Pennsylvania – fiscal years ended June 30, 2014 and after

Other States – fiscal years ended June 30, 2013 and after

Accounts Receivable

Allowance for Doubtful Accounts	Balance Beginning of Year		Charges to Expense		Write-offs /Payments			Balance End of Year

2017	$	63	$	20	$	(5	)	$	78
2016	$	34	$	34	$	(5	)	$	63
2015	$	23	$	22	$	(11	)	$	34

Stock-Based Compensation

	Year Ended June 30,
	2017		2016		2015
Stock-based compensation expense included in:
Cost of revenue	$	41	$	31	$	22
Selling, general and administrative		455		645		489
Total	$	496	$	676	$	511

The fair value of the Company’s stock options was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:

	Year Ended June 30,
	2017			2016			2015

Weighted average risk-free interest rate		1.1	%		1.0	%		0.4	%
Weighted average expected volatility		47	%		45	%		45	%
Weighted average expected life (in years)		5.15			4.56			3.49
Dividend yield		-			-			-

The Company considers an estimated forfeiture rate for stock options based on historical experience and the anticipated forfeiture rates during the future contract life.

Cash and Cash Equivalents

Inventory

Property, Plant and Equipment

Goodwill and Other Identifiable Intangible Assets

Intangible Assets

Shipping and Handling Fees and Costs

Additional Product Related Costs

Additional Product Related Costs: The Company records inbound shipping, purchasing and receiving costs, inspection costs, warehousing costs and other product related costs as cost of revenues.

Advertising Costs

Research and Development Costs

Realization of Long-lived Assets

Employee Benefit Plans

Net Income (Loss) Per Share

Fair Value of Financial Instruments

Fair Value Measurements

Level 1 – Quoted prices in active markets for identical assets or liabilities.

Level 2 – Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities).

Level 3 – Significant unobservable inputs (including our own assumptions in determining fair value).

Segment Reporting

Use of Estimates

Recently Issued Accounting Standards

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

12 Months Ended

Jun. 30, 2017

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]

Allowance for doubtful accounts

The Company has a history of minimal uncollectible accounts. See rollforward of allowance activity below:

Allowance for Doubtful Accounts	Balance Beginning of Year		Charges to Expense		Write-offs /Payments			Balance End of Year

2017	$	63	$	20	$	(5	)	$	78
2016	$	34	$	34	$	(5	)	$	63
2015	$	23	$	22	$	(11	)	$	34

Schedule of stock-based compensation expense

Total stock-based compensation expense for the fiscal years ended June 30, 2017, 2016 and 2015 are as follows:

	Year Ended June 30,
	2017		2016		2015
Stock-based compensation expense included in:
Cost of revenue	$	41	$	31	$	22
Selling, general and administrative		455		645		489
Total	$	496	$	676	$	511

Schedule of stock option valuation assumptions

The fair value of the Company’s stock options was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions:

	Year Ended June 30,
	2017			2016			2015

Weighted average risk-free interest rate		1.1	%		1.0	%		0.4	%
Weighted average expected volatility		47	%		45	%		45	%
Weighted average expected life (in years)		5.15			4.56			3.49
Dividend yield		-			-			-

PROPERTY, PLANT AND EQUIPMENT (Tables)

12 Months Ended

Jun. 30, 2017

PROPERTY, PLANT AND EQUIPMENT [Abstract]

Property, plant and equipment

At June 30, 2017 and 2016, property, plant and equipment consisted of the following (in thousands):

		June 30,
	Useful Life	2017		2016
Furniture and fixtures	3 to 5 years	$	260	$	247
Plant and equipment	3 to 17 years		7,975		6,524
Manufacturing	15 years		220		220
Computers and software	3 to 5 years		2,246		2,009
Leasehold improvements	Life of Lease		2,681		964
Land			19		19
Construction-in-progress			347		1,372
			13,748		11,355
Less: accumulated depreciation			7,205		6,323

Net property, plant and equipment		$	6,543	$	5,032

INCOME TAXES (Tables)

12 Months Ended

Jun. 30, 2017

INCOME TAXES [Abstract]

Components of income tax expense

The components of income tax expense are as follows (in thousands):

	Year ended June 30,
	2017		2016		2015

Current
Federal	$	-	$	-	$	29
State		4		24		83
	$	4	$	24	$	112

Effective income tax rate reconciliation

The reconciliation of the statutory income tax rate to the Company’s effective income tax rate for the fiscal years ended June 30, 2017, 2016 and 2015 is as follows:

	Year Ended June 30,
	2017			2016			2015

Statutory rate		34.0	%		34.0	%		34.0	%
State income taxes, net		(4.5	%)		(18.6	%)		5.3	%
Meals and entertainment		(1.5	%)		38.7	%		1.2	%
AMT and research and development credits		0.0	%		(218.9	%)		0.0	%
Other		0.2	%		1.5	%		0.0	%
Effective rate before valuation allowance		28.2	%		(163.3	%)		40.5	%

Change in valuation allowance		(28.5	%)		228.2	%		(31.7	%)
Effective tax rate